ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer
Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to assess the effects of ZD4054 on prostate cancer that
has spread to the bones by using new imaging techniques. In particular, this study will use
fluorodeoxyglucose (FDG) and 18F-Sodium Fluoride (NaF) PET/computed tomography (CT) and MRI
scans to look for changes in bone metastasis after ZD4054 therapy.